Literature DB >> 11772703

Use of atypical antipsychotics during pregnancy and the risk of neural tube defects in infants.

Gideon Koren1, Tony Cohn, David Chitayat, Bhushan Kapur, Gary Remington, Diane Myles Reid, Robert B Zipursky.   

Abstract

OBJECTIVE: Folate deficiency in early pregnancy and maternal adiposity, independent of folate intake, lead to a greater risk of neural tube defects in infants. Atypical antipsychotics cause various degrees of weight gain. The authors assessed folate status and obesity among patients with schizophrenia receiving atypical antipsychotics.
METHOD: A sample of 70 inpatients and outpatients (21 of them women) who were taking antipsychotics was randomly selected. Body weight, body mass index, daily folate intake, and folate serum concentrations were determined.
RESULTS: The majority of the patients were overweight. Only eight of 37 patients had folate intake above 400 microg/day, the level shown to be protective against neural tube defects. Mean serum folate was significantly lower than in a general hospital group of 810 patients.
CONCLUSIONS: Women with schizophrenia who take atypical antipsychotics have a higher risk of neural tube defects in their infants because of the associated low intake of folate and obesity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11772703     DOI: 10.1176/appi.ajp.159.1.136

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  8 in total

1.  Safety of antipsychotic drugs for pregnant and breastfeeding women with non-affective psychosis.

Authors:  Louise Howard; Roger Webb; Kathryn Abel
Journal:  BMJ       Date:  2004-10-23

2.  Prenatal antipsychotic exposure and neuromotor performance during infancy.

Authors:  Katrina C Johnson; Jamie L LaPrairie; Patricia A Brennan; Zachary N Stowe; D Jeffrey Newport
Journal:  Arch Gen Psychiatry       Date:  2012-08

Review 3.  Use of antipsychotics in the management of schizophrenia during pregnancy.

Authors:  Mátyás Trixler; Agnes Gáti; Sándor Fekete; Tamás Tényi
Journal:  Drugs       Date:  2005       Impact factor: 9.546

4.  How are parental practices and attitudes towards corporal punishment related to child academic, developmental, or psychological-emotional dysfunctioning?

Authors:  Roberto Grujicic; Oliver Toskovic; Ljiljana B Lazarević; Vanja Mandic-Maravic; Marija Mitkovic-Voncina; Ana Radanović; Jelena Radosavljev-Kircanski; Marina Videnović; Tatjana Pekmezovic; Milica Pejovic Milovancevic
Journal:  Eur Child Adolesc Psychiatry       Date:  2022-08-10       Impact factor: 5.349

5.  Randomized multicenter investigation of folate plus vitamin B12 supplementation in schizophrenia.

Authors:  Joshua L Roffman; J Steven Lamberti; Eric Achtyes; Eric A Macklin; Gail C Galendez; Lisa H Raeke; Noah J Silverstein; Jordan W Smoller; Michele Hill; Donald C Goff
Journal:  JAMA Psychiatry       Date:  2013-05       Impact factor: 21.596

6.  Biochemical, physiological and clinical effects of l-methylfolate in schizophrenia: a randomized controlled trial.

Authors:  J L Roffman; L J Petruzzi; A S Tanner; H E Brown; H Eryilmaz; N F Ho; M Giegold; N J Silverstein; T Bottiglieri; D S Manoach; J W Smoller; D C Henderson; D C Goff
Journal:  Mol Psychiatry       Date:  2017-03-14       Impact factor: 15.992

7.  Meningomyelocele on Exposure to Clozapine During Perinatal Period.

Authors:  Prakruthi Narayanaswamy; K S Shaji; T P Sumesh
Journal:  Indian J Psychol Med       Date:  2019 Jul-Aug

Review 8.  [Antipsychotics during pregnancy: a systematic review].

Authors:  Thomas Hillemacher; Susanne Simen; Marie-Kathrin Rehme; Helge Frieling
Journal:  Nervenarzt       Date:  2020-09-30       Impact factor: 1.214

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.